Divergent Trajectories and Risk Factor Attribution of Chronic Obstructive Pulmonary Disease Burden in China and the United States, 1990-2023: An Age-Period-Cohort Analysis with Projections to 2035 Based on the Global Burden of Disease Study 2023

1990-2023年中国和美国慢性阻塞性肺疾病负担的不同发展轨迹及风险因素归因:基于2023年全球疾病负担研究的年龄-时期-队列分析及至2035年的预测

阅读:1

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) remains a leading cause of global mortality. China and the United States, the world's two largest economies accounting for 40% of global COPD burden, lack comprehensive comparative analyses of long-term trends and risk factor attribution. OBJECTIVE: This study aimed to compare COPD burden trends, decompose age-period-cohort effects, quantify risk factor contributions, and project future trajectories in China and the United States from 1990 to 2023 with forecasts to 2035. METHODS: We analyzed Global Burden of Disease Study 2023 data for China and the United States, examining incidence, prevalence, mortality, and disability-adjusted life years (DALYs) stratified by sex and 17 age groups. Joinpoint regression identified temporal inflection points. Age-period-cohort models decomposed burden into independent effects. Risk factor attribution analyzed eight major exposures. Bayesian methods projected burden to 2035. RESULTS: China demonstrated remarkable declines in age-standardized mortality (58.68% decrease to 46.60 per 100,000) and DALY rates (61.12% decrease to 777.86 per 100,000), with dramatic risk factor reductions: particulate matter pollution declined 82.21%, smoking 68.48%. Conversely, the United States exhibited increasing age-standardized mortality (8.90% increase to 28.89 per 100,000), with female mortality rising 45.64% and smoking-attributable burden declining only 14.09%. Period effects deteriorated in the United States (relative risk: 0.67 to 1.34) while improving in China (1.20 to 0.83). Projections indicated Chinese deaths would surge 135.9% by 2035 despite declining age-standardized rates, while American deaths would increase 30.1% with rising age-standardized rates. CONCLUSION: Substantial COPD burden reductions are achievable through comprehensive risk factor control as demonstrated by China's success, while persistent deterioration in the United States highlights critical prevention gaps requiring urgent intervention to avert projected burden escalation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。